Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Feasibility of accurate differentiation between malignant and benign tissue using the FOSTI device on surgically removed tissue
Characterization of the optical fiber sensor's interaction with the tissue.
Creating a database of tissue lesions and their 'optical signature' (lesion classifier).
Optimization of the FOSTI device by minimizing the false-positive and false-negative results.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
The study population will consist of subjects who undergo cancer surgery
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Anatoliy Babchenko | Optivasive Ltd. | Study Director |
Not provided
Not provided
| ID | Term |
|---|---|
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided